Frontlight ResearchEarly access
Trial site
Juravinski Cancer Center
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- Prostate cancer1 trial
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Phase 32 trials
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Arcus Biosciences, Inc.1 trial
- ImmunoVaccine Technologies, Inc. (IMV Inc.)1 trial
- Leiden University Medical Center1 trial
- Ontario Clinical Oncology Group (OCOG)1 trial
- pharmaand GmbH1 trial
- and 1 more
Running trials
Recruiting
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
Recruiting
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer1 recruiting
- Multiple myeloma1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026